Skip to main content

Roivant Sciences Ltd.

ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001635088

In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 9 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Roivant Sciences Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
4 insiders, $52.8M in total
Insiders trading
4
Net value
−$52.8M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Roivant Sciences Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Roivant Sciences Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Humes JenniferChief Accounting Officer106,419Sep 22, 20265
Pulik RichardCFO269,681Sep 22, 202611
Manchester Keith SDirector1,753,457Sep 18, 20265
Gold Daniel AllenDirector8,965,815Sep 18, 20266
Oren IlanDirector123,680Sep 18, 20266
Momtazee James CDirector111,959Sep 18, 20266
Fitzgerald MeghanDirector41,162Sep 18, 20266
Epperly Melissa B,Director14,954Sep 18, 20269
Venker EricPresident & Immunovant CEO1,599,154Sep 1, 202617
Sukhatme MayukhPresident & CIO18,630,739Aug 21, 20268
Gline MatthewCEO16,659,945Jul 2, 20264
Torti FrankPresident and Vant Chair13,536,202Jul 2, 20264
QVT Financial LPOther: Director by Deputization13,689,166IndirectJun 30, 20264
Ramaswamy Vivek10% Owner33,653,755Dec 15, 20252
Kumar RakhiChief Accounting Officer162,306Feb 24, 20250
SoftBank Vision Fund L.P.10% Owner73,031,667IndirectOct 2, 20230
SVF Holdings (UK) LLP10% Owner73,031,667IndirectOct 2, 20230
SVF Investments (UK) Ltd10% Owner73,031,667IndirectOct 2, 20230
SB Investment Advisers (UK) Ltd10% Owner73,031,667IndirectOct 2, 20230
Viking Global Investors LP10% Owner12,884,307IndirectJun 26, 20230
Halvorsen Ole Andreas10% Owner12,884,307IndirectJun 26, 20230
Ott David C.10% Owner12,884,307IndirectJun 26, 20230
Viking Global Opportunities Portfolio GP LLC10% Owner12,884,307IndirectJun 26, 20230
Viking Global Opportunities GP LLC10% Owner12,884,307IndirectJun 26, 20230
Viking Global Opportunities Illiquid Investments Sub-Master LP10% Owner12,884,307IndirectJun 26, 20230
Shabet Rose Sharon10% Owner12,884,307IndirectJun 26, 20230
Viking Global Opportunities Parent GP LLC10% Owner12,884,307IndirectJun 26, 20230
Viking Global Performance LLC10% Owner12,884,307IndirectJun 26, 20230
Viking Global Equities II LP10% Owner12,884,307IndirectJun 26, 20230
Viking Long Fund Master Ltd.10% Owner12,884,307IndirectJun 26, 20230
Viking Long Fund GP LLC10% Owner12,884,307IndirectJun 26, 20230
Viking Global Equities Master Ltd.10% Owner12,884,307IndirectJun 26, 20230
Sumitomo Pharma Co., Ltd.10% Owner71,251,083IndirectJun 26, 20230
Sumitomo Chemical Co., Ltd.10% Owner71,251,083IndirectJun 26, 20230
Dexxon Holdings Ltd.10% Owner102,849,443Nov 14, 20220
Oren Dan10% Owner102,849,443Nov 14, 20220
Dexcel Pharma Technologies Ltd.10% Owner102,849,443Nov 14, 20220
Lo AndrewDirector52,142Sep 19, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 22, 2025 (view filing)Aug 202 daysVenker EricPresident & Immunovant CEOSSale−100.0K$11.72−$1.17M−5.7%1.65M after10b5-1
Jul 23, 2025 (view filing)Jul 212 daysVenker EricPresident & Immunovant CEOSSale−100.0K$11.52−$1.15M−6.4%1.46M after10b5-1
Jun 24, 2025 (view filing)Jun 204 daysVenker EricPresident & COOSSale−100.0K$11.45−$1.15M−6.4%1.46M after10b5-1
Jun 23, 2025 (view filing)Jun 18-205 daysRamaswamy Vivek10% OwnerSSale−1.14M$11.46−$13.1M−3.0%37.3M after2 lots
Jun 6, 2025 (view filing)Jun 4-62 daysRamaswamy Vivek10% OwnerSSale−748.2K$11.30−$8.45M−1.9%38.4M after2 lots
Jun 4, 2025 (view filing)Jun 2-32 daysVenker EricPresident & COOSSale−1.00M$11.15−$11.2M−40.6%1.46M after2 lots
May 22, 2025 (view filing)May 202 daysVenker EricPresident & COOSSale−100.0K$10.95−$1.09M−8.5%1.08M after10b5-1
May 8, 2025 (view filing)May 6-72 daysRamaswamy Vivek10% OwnerSSale−899.0K$11.27−$10.1M−2.2%39.2M after2 lots
Apr 22, 2025 (view filing)Apr 211 dayVenker EricPresident & COOSSale−100.0K$10.22−$1.02M−8.2%1.12M after10b5-1
Mar 24, 2025 (view filing)Mar 20-244 daysVenker EricPresident & COOSSale−750.0K$10.92−$8.19M−40.0%1.13M after2 lots10b5-1
Feb 24, 2025 (view filing)Feb 204 daysVenker EricPresident & COOSSale−100.0K$10.65−$1.06M−10.0%896.9K after
Feb 18, 2025 (view filing)Feb 135 daysKumar RakhiChief Accounting OfficerSSale−227.5K$10.43−$2.37M−58.2%163.3K after
Feb 14, 2025 (view filing)Feb 12-132 daysVenker EricPresident & COOSSale−435.4K$10.47−$4.56M−32.7%896.9K after2 lots
Jan 22, 2025 (view filing)Jan 211 dayVenker EricPresident & COOSSale−100.0K$11.28−$1.13M−12.0%732.3K after10b5-1
Dec 31, 2024 (view filing)Dec 27-304 daysVenker EricPresident & COOSSale−354.6K$11.68−$4.14M−32.4%741.0K after2 lots
Dec 26, 2024 (view filing)Dec 23-263 daysSukhatme MayukhPres&Chief Investment OfficerSSale−886.2K$12.01−$10.6M−4.5%18.8M after3 lots
Dec 26, 2024 (view filing)Dec 206 daysVenker EricPresident & COOSSale−100.0K$11.49−$1.15M−14.4%595.6K after10b5-1
Dec 20, 2024 (view filing)Dec 182 daysSukhatme MayukhPres&Chief Investment OfficerSSale−412.6K$12.05−$4.97M−2.1%18.8M after
Nov 22, 2024 (view filing)Nov 202 daysVenker EricPresident & COOSSale−100.0K$11.32−$1.13M−14.2%606.5K after10b5-1
Oct 22, 2024 (view filing)Oct 211 dayVenker EricPresident & COOSSale−100.0K$11.65−$1.17M−13.9%617.5K after
Sep 26, 2024 (view filing)Sep 25-261 dayQVT Financial LPOther: Director by DeputizationSSale−926.0K$11.82−$10.9M−4.0%22.2M after2 lots
Sep 26, 2024 (view filing)Sep 24-252 daysManchester Keith SDirectorSSale−503.0K$11.67−$5.87M−28.3%1.28M after2 lots
Sep 26, 2024 (view filing)Sep 24-252 daysGold Daniel AllenDirectorSSale−2.56M$11.68−$29.9M−35.1%4.73M after2 lots
Sep 26, 2024 (view filing)Sep 24-262 daysGold Daniel AllenDirectorSSale−1.87M$11.75−$22.0M−7.8%22.2M after4 lots
Sep 24, 2024 (view filing)Sep 231 dayKumar RakhiChief Accounting OfficerSSale−250.0K$11.89−$2.97M−54.4%209.3K after10b5-1
Sep 24, 2024 (view filing)Sep 231 dayGline MatthewCEOSSale−1.98M$11.79−$23.4M−10.0%17.9M after10b5-1
Feb 9, 2024 (view filing)Feb 9Same dayVenker EricPresident & COOSSale−97.0K$10.92−$1.06M−15.4%532.2K after10b5-1
Jan 3, 2024 (view filing)Jan 21 dayRamaswamy Vivek10% OwnerSSale−3.00M$11.05−$33.1M−5.5%51.9M after
Oct 4, 2023 (view filing)Oct 2-52 daysVenker EricChief Operating OfficerSSale−1.20M$10.43−$12.5M−66.8%595.4K after3 lots10b5-1
Oct 2, 2023 (view filing)9:00 PM ETSep 284 daysSoftBank Vision Fund L.P. and 3 others10% OwnerSSale−10.0M$12.60−$126.0M−12.0%73.0M after
Oct 2, 2023 (view filing)Sep 284 daysManchester Keith SDirectorSSale−6.90M$11.55−$79.7M−57.9%5.02M after4 lots
Oct 2, 2023 (view filing)Sep 284 daysQVT Financial LP10% Owner, Other: Director by DeputizationSSale−10.0M$11.55−$115.5M−66.6%5.02M after6 lotsDuplicate filing
Oct 2, 2023 (view filing)Sep 284 daysGold Daniel AllenDirectorSSale−10.0M$11.55−$115.5M−66.6%5.02M after6 lots
Sep 29, 2023 (view filing)Sep 272 daysVenker EricPresident & COOSSale−500.0K$13.02−$6.51M−45.6%595.4K after
Sep 12, 2023 (view filing)Sep 84 daysVenker EricChief Operating OfficerSSale−106.4K$12.19−$1.30M−14.8%611.8K after
Sep 12, 2023 (view filing)Sep 84 daysKumar RakhiChief Accounting OfficerSSale−99.3K$12.18−$1.21M−33.4%197.9K after
Sep 7, 2023 (view filing)Sep 52 daysKumar RakhiChief Accounting OfficerSSale−1.72K$12.00−$20.7K−0.9%197.9K after
Sep 6, 2023 (view filing)Sep 1-65 daysVenker EricChief Operating OfficerSSale−94.0K$11.91−$1.12M−13.3%611.8K after3 lots
Aug 16, 2023 (view filing)Aug 142 daysVenker EricChief Operating OfficerSSale−59.8K$11.89−$711.2K−8.7%627.9K after
Aug 7, 2023 (view filing)Aug 34 daysVenker EricChief Operating OfficerSSale−44.6K$11.93−$532.4K−6.6%627.9K after
Aug 3, 2023 (view filing)Aug 1-32 daysKumar RakhiChief Accounting OfficerSSale−4.02K$12.00−$48.2K−2.0%199.3K after2 lots
Aug 2, 2023 (view filing)Jul 31-Aug 22 daysVenker EricChief Operating OfficerSSale−195.2K$11.91−$2.32M−23.7%627.9K after3 lots
Jul 27, 2023 (view filing)Jul 25-272 daysVenker EricChief Operating OfficerSSale−125.5K$10.91−$1.37M−16.7%627.9K after3 lots
Jul 24, 2023 (view filing)Jul 20-244 daysVenker EricPresident & COOSSale−374.5K$11.19−$4.19M−36.8%644.2K after3 lots
Jul 18, 2023 (view filing)Jul 14-184 daysKumar RakhiChief Accounting OfficerSSale−635$12.00−$7.62K−0.8%82.1K after2 lots
Jun 26, 2023 (view filing)5:11 PM ETJun 224 daysViking Global Investors LP and 7 others10% OwnerSSale−13.0M$9.90−$128.7M−50.2%12.9M after4 lotsDuplicate filing
Jun 26, 2023 (view filing)5:10 PM ETJun 224 daysViking Global Performance LLC and 7 others10% OwnerSSale−13.0M$9.90−$128.7M−50.2%12.9M after4 lots
Jun 26, 2023 (view filing)4:05 PM ETJun 224 daysSumitomo Pharma Co., Ltd. and 1 other10% OwnerSSale−15.1M$8.60−$130.0M−17.5%71.3M after
Jun 13, 2023 (view filing)Jun 94 daysKumar RakhiChief Accounting OfficerSSale−43.9K$9.93−$435.9K−18.1%198.6K after
Jun 9, 2023 (view filing)Jun 7-92 daysVenker EricPresident & COOSSale−299.6K$9.91−$2.97M−31.2%660.1K after2 lots